CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
New additions expand company’s rapidly growing product portfolio LEHI, Utah, Jan. 5, 2026 /PRNewswire/ — CivicaScript®, LLC, a nonprofit company…
